These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36873733)

  • 1. Bone tumor-homing nanotherapeutics for prolonged retention in tumor microenvironment and facilitated apoptotic process
    Kang NW; Visetvichaporn V; Nguyen DT; Shin EK; Kim D; Kim MJ; Yoo SY; Lee JY; Kim DD
    Mater Today Bio; 2023 Apr; 19():100591. PubMed ID: 36873733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyapatite-binding albumin nanoclusters for enhancing bone tumor chemotherapy.
    Kang NW; Lee JY; Kim DD
    J Control Release; 2022 Feb; 342():111-121. PubMed ID: 34990700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondroitin Sulfate Targeting Nanodrug Achieves Near-Infrared Fluorescence-Guided Chemotherapy Against Triple-Negative Breast Primary and Lung Metastatic Cancer.
    Huang C; Li C; Cai J; Chen J; Wang B; Li M; Zhou W; Wang J; Zhang P; Zhang JV
    Int J Nanomedicine; 2022; 17():5547-5563. PubMed ID: 36444194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Characterization of Placental Chondroitin Sulfate A (plCSA)-Targeting Lipid-Polymer Nanoparticles.
    Zhang B; Zheng M; Cai L; Fan X
    J Vis Exp; 2018 Sep; (139):. PubMed ID: 30295666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the therapeutic efficacy of the MAP regimen using thiamine pyrophosphate-decorated albumin nanoclusters in osteosarcoma treatment.
    Yoo SY; Mun YH; Kang NW; Koo JM; Lee DH; Yoo JH; Lee SM; Koh S; Park JC; Kim T; Shin EK; Lee HS; Sim J; Kang KW; Kim SK; Cho CW; Kim MG; Kim DD; Lee JY
    Bioeng Transl Med; 2023 Nov; 8(6):e10472. PubMed ID: 38023714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placenta-specific drug delivery by trophoblast-targeted nanoparticles in mice.
    Zhang B; Tan L; Yu Y; Wang B; Chen Z; Han J; Li M; Chen J; Xiao T; Ambati BK; Cai L; Yang Q; Nayak NR; Zhang J; Fan X
    Theranostics; 2018; 8(10):2765-2781. PubMed ID: 29774074
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor microenvironment-labile polymer-doxorubicin conjugate thermogel combined with docetaxel for in situ synergistic chemotherapy of hepatoma.
    Zhang Y; Zhang J; Xu W; Xiao G; Ding J; Chen X
    Acta Biomater; 2018 Sep; 77():63-73. PubMed ID: 30006312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of mevalonate pathway prevents ischemia-induced cardiac dysfunction in rats via RhoA-independent signaling pathway.
    Yang Y; Rong X; Lv X; Jiang W; Yang Y; Lai D; Xu S; Fu G
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28665545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
    Sun B; Deng C; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered nanomedicine for myeloma and bone microenvironment targeting.
    Swami A; Reagan MR; Basto P; Mishima Y; Kamaly N; Glavey S; Zhang S; Moschetta M; Seevaratnam D; Zhang Y; Liu J; Memarzadeh M; Wu J; Manier S; Shi J; Bertrand N; Lu ZN; Nagano K; Baron R; Sacco A; Roccaro AM; Farokhzad OC; Ghobrial IM
    Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10287-92. PubMed ID: 24982170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoblast-like cell (MC3T3-E1) proliferation on bioerodible polymers: an approach towards the development of a bone-bioerodible polymer composite material.
    Elgendy HM; Norman ME; Keaton AR; Laurencin CT
    Biomaterials; 1993; 14(4):263-9. PubMed ID: 8386557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.
    Virtanen SS; Väänänen HK; Härkönen PL; Lakkakorpi PT
    Cancer Res; 2002 May; 62(9):2708-14. PubMed ID: 11980672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted osteosarcoma chemotherapy using RGD peptide-installed doxorubicin-loaded biodegradable polymeric micelle.
    Fang Z; Sun Y; Xiao H; Li P; Liu M; Ding F; Kan W; Miao R
    Biomed Pharmacother; 2017 Jan; 85():160-168. PubMed ID: 27930982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy.
    Zhang L; Qin Y; Zhang Z; Fan F; Huang C; Lu L; Wang H; Jin X; Zhao H; Kong D; Wang C; Sun H; Leng X; Zhu D
    Acta Biomater; 2018 Jul; 75():371-385. PubMed ID: 29777957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Delivery Prodigiosin to Choriocarcinoma by Peptide-Guided Dendrigraft Poly-l-lysines Nanoparticles.
    Zhao K; Li D; Cheng G; Zhang B; Han J; Chen J; Wang B; Li M; Xiao T; Zhang J; Zhou D; Jin Z; Fan X
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhoA enhances osteosarcoma resistance to MPPa-PDT via the Hippo/YAP signaling pathway.
    Zhan F; He T; Chen Z; Zuo Q; Wang Y; Li Q; Zhong S; Ou Y
    Cell Biosci; 2021 Oct; 11(1):179. PubMed ID: 34627383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.
    Fisher JE; Rogers MJ; Halasy JM; Luckman SP; Hughes DE; Masarachia PJ; Wesolowski G; Russell RG; Rodan GA; Reszka AA
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):133-8. PubMed ID: 9874784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer.
    Ye WL; Zhao YP; Li HQ; Na R; Li F; Mei QB; Zhao MG; Zhou SY
    Sci Rep; 2015 Sep; 5():14614. PubMed ID: 26419507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasmall gold nanosatellite-bearing transformable hybrid nanoparticles for deep tumor penetration.
    Son S; Deepagan VG; Shin S; Ko H; Min J; Um W; Jeon J; Kwon S; Lee ES; Suh M; Lee DS; Park JH
    Acta Biomater; 2018 Oct; 79():294-305. PubMed ID: 30134209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment.
    Noack AK; Lucas H; Chytil P; Etrych T; Mäder K; Mueller T
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.